The event, sponsored by J.P. Morgan, Numis, Penningtons Manches, PwC and Consilium Strategic Communications, and held in partnership with the MedCity, BioIndustry Association (BIA) and One Nucleus, will highlight the significant investment opportunities within the UK healthcare sector available to investors. This invitation-only, free to attend conference will showcase leading public and private UK life sciences companies through a series of short presentations and themed panel sessions. Jo Johnson MP, Minister of State for Universities, Science, Research and Innovation will deliver a keynote discussing Government strategies that will impact the Healthcare sector. Panels and Keynote presentations will tackle issues around most topical areas of healthcare technology and feature key representatives of Pfizer, Syncona, Immunocore, Oncimmune, Clinigen, BTG, Motif Bio, Kymab and many others.
| 08:30 |
Registration |
| 09:00 |
Welcome
• Xavier Rolet, CEO, London Stock Exchange Group
|
| 09:05 |
Policy Keynote
• Lord Prior of Brampton, Parliamentary Under Secretary of State, Department for Business, Energy and Industrial, HMG
|
| 09:25 |
Markets Keynote
• James Mitford, Managing Director, JPM
|
| 09:35 |
Industry Keynote
• Sir Robert Lechler, Vice Principal, Kings College London
|
| 09:55 |
Info Shot
• Martin Murphy, CEO, Syncona
|
| 10:10 |
Panel I – Cell/Gene Therapies/Personalised Medicine Moderator: Jo Pisani, Partner, Strategy& (PwC) Panel:
• Jonathan Appleby, CSO,Cell and Gene Therapy, GSK
• Geoffrey Hamilton-Fairley, CEO, Oncimmune
• Mike Stocum, CEO, Inivata
• Darrin Disley, CEO, Horizon Discovery
|
| 10:40 |
Info Shot
• Shaun Chilton, CEO, Clinigen
|
| 10:55 |
Coffee and Networking |
| 11:25 |
Info Shot
• Louise Makin, CEO, BTG
|
| 11:40 |
Panel II – Oncology Moderator: Jim Kinnier-Wilson, Partner, Penningtons Manches Panel:
• Lauren Domas, Head of Strategy and Operations, BTG Interventional Oncology
• Eliot Forster, CEO, Immunocore
• Steve Arkinstall, CSO, Kymab
Gregg Sando, CEO, Cell Medica
|
| 12:10 |
Info Shot • James Ward-Lilley, CEO, Vectura |
| 12:25 |
Panel III – Anti Bacterial/microbiome Moderator: Sarah Haywood, CEO, MedCity Panel:
• Richard Mason, Head of J&J Innovation, London, J&J
• Graham Lumsden, CEO, Motif Bio
• Neil Murray, CEO, Redx
• Glyn Edwards, CEO, Summit
|
| 12:55 |
Closing Keynote (technology) – Eli Lilly & Co – Why the UK?
• Trafford Clarke, Managing Director, Lilly Research Centre
|
| 13:15 |
Closing remarks
• Michael Meade, Managing Director, Corporate Broking and Advisory, Numis
|
| 13:20 |
Lunch |
